Does CLOTIAZEPAM Cause Hepatocellular injury? 14 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Hepatocellular injury have been filed in association with CLOTIAZEPAM. This represents 4.3% of all adverse event reports for CLOTIAZEPAM.
14
Reports of Hepatocellular injury with CLOTIAZEPAM
4.3%
of all CLOTIAZEPAM reports
0
Deaths
12
Hospitalizations
How Dangerous Is Hepatocellular injury From CLOTIAZEPAM?
Of the 14 reports, 12 (85.7%) required hospitalization, and 12 (85.7%) were considered life-threatening.
Is Hepatocellular injury Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLOTIAZEPAM. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does CLOTIAZEPAM Cause?
Coma (65)
Toxicity to various agents (54)
Somnolence (52)
Suicide attempt (31)
Fall (25)
Poisoning (24)
Confusional state (21)
Dizziness (19)
Hypotension (19)
Drug use disorder (17)
What Other Drugs Cause Hepatocellular injury?
ACETAMINOPHEN (1,761)
METHOTREXATE (683)
ATORVASTATIN (610)
SULFAMETHOXAZOLE\TRIMETHOPRIM (415)
ENOXAPARIN (365)
TRAMADOL (349)
AMOXICILLIN (347)
ESOMEPRAZOLE (341)
PANTOPRAZOLE (340)
VINCRISTINE (306)
Which CLOTIAZEPAM Alternatives Have Lower Hepatocellular injury Risk?
CLOTIAZEPAM vs CLOTRIMAZOLE
CLOTIAZEPAM vs CLOXACILLIN
CLOTIAZEPAM vs CLOXAZOLAM
CLOTIAZEPAM vs CLOZAPINE
CLOTIAZEPAM vs CLOZARIL